Clinical Trial: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116551) titled 'Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis' on July 22.

Brief Summary: The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.

Study Start Date: Oct. 24

Study Type: INTERVENTIONAL

Condition: Symptomatic Severe Aortic Stenosis

Intervention: DEVICE: Abbott BE TAVI System

Abbott BE TAVI System

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Abbott Medical Devices

Published by HT Digital Content Services with permission ...